Cowen and Company’s Cingulate CING Stock Holding History

Cowen and Company’s Portfolio CING Stock Details CING Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,917	Closed	-$105K	–	634
2024 Q1	$105K	Buy	+7,917	New	+$254K	﹤0.01%	289

Other funds holding CING

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cowen and Company's CING Position: Q2 2024 in Review

Cowen and Company sold out of Cingulate (CING) in Q2 2024, closing a stake of 7,917 shares — an estimated $105K sold.

Cowen and Company first reported a position in CING in Q1 2024 and held it in 1 quarter. The position peaked at $105K in Q1 2024. 9 funds tracked by Wall St. Rank hold CING as of Q2 2024.

Cowen and Company reported no remaining Cingulate position as of Q2 2024 after selling out during the quarter.
Cowen and Company sold 7,917 Cingulate shares in Q2 2024, an estimated $105K.
Cowen and Company first reported a position in Cingulate in Q1 2024 and held it in 1 quarter.
Cowen and Company's Cingulate position peaked at $105K in Q1 2024.
9 funds tracked by Wall St. Rank held Cingulate as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.